l-carnitine and prostate cancer Acetyl-l-carnitine is an anti-angiogenic agent targeting the VEGFR2 CXCR4 pathways Carnitine | Memorial Sloan Kettering
Carnitine Memorial Sloan Kettering Cancer Center The carnitine system and cancer metabolic plasticity Cell Death & Disease l carnitine increased androgen receptors l carnitine receptor Drug Insight: role of the androgen receptor in the development and progression of prostate cancer Evolution of androgen receptor targeted Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy ACS Pharmacology & Translational Science
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21



